Jessica Sachs

Jessica Sachs is the current Chief Medical Officer at Cogent Biosciences. Jessica has previous experience working as a Senior Medical Director at Takeda from January 2012 to April 2017, an Associate Director at Sanofi Genzyme from January 2010 to December 2012, and an Attending in Pediatric Bone Marrow Transplant at Dana-Farber Cancer Institute from January 2007 to December 2010. Jessica Sachs also completed a Fellowship in Pediatric Hematology/Oncology at Boston Children's Hospital from January 2004 to December 2007 and a Residency in Pediatrics at Tufts-New England Medical Center from January 2001 to December 2004.

Jessica Sachs has a Doctor of Medicine (M.D.) from Washington University School of Medicine in St. Louis in the field of medicine. Jessica also has a Scandinavian Studies degree from the University of Gothenburg in the field of Scandinavian Studies. Jessica has a Bachelor’s Degree in Biology from Duke University. Jessica is certified from the American Academy of Pediatrics.

They work with John Green - CFO, Sara Saltzman - SVP, Regulatory Affairs, and Evan Kearns - Chief Legal Officer & Corporate Secretary. Jessica Sachs reports to Andrew Robbins, CEO & President. A direct report to Jessica Sachs is and Dana Martin - SVP, Medical Affairs & Chief Patient Officer.